¼¼°èÀÇ Àü±â°æ·Ã¿ä¹ý ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Global Electroconvulsive Therapy Market, By Product Type, By Application, By End User, By Geography
»óǰÄÚµå : 1707347
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,267,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,749,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,928,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Àü ¼¼°è Àü±â°æ·Ã¿ä¹ý ½ÃÀå ±Ô¸ð´Â 2025³â¿¡ 1,790¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç 2032³â¿¡´Â 2,180¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç 2025³âºÎÅÍ 2032³â±îÁö 2.9%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 1,790¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR: 2.90% 2032³â °¡Ä¡ ¿¹Ãø 2,180¸¸ ´Þ·¯
±×¸². Àü±â°æ·Ã¿ä¹ý ¼¼°è ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2025³â
Global Electroconvulsive Therapy Market-IMG1

Àü±â°æ·Ã¿ä¹ý(ECT)Àº ´Ù¸¥ Ä¡·á¹ý¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â ÁßÁõ ¿ì¿ïÁõÀ̳ª ¾ç±Ø¼º Àå¾Ö ȯÀÚ¿¡°Ô °¡Àå ¸¹ÀÌ »ç¿ëµÇ´Â Ä¡·á¹ýÀÔ´Ï´Ù. ȯÀÚ¿¡°Ô ¸¶ÃëÇÑ »óÅ¿¡¼­ ³ú¿¡ ªÀº ½Ã°£ µ¿¾È Àü±â ÀÚ±ØÀ» °¡ÇÕ´Ï´Ù. Ãʱ⠻ç¿ë¿¡´Â ¿À¸íÀÌ ÀÖ¾úÁö¸¸, ECT´Â Å©°Ô ¹ßÀüÇÏ¿© ƯÁ¤ Á¤½Å Áúȯ¿¡ ´ëÇÑ ¾ÈÀüÇϰí È¿°úÀûÀÎ Ä¡·á¹ýÀ¸·Î ¿©°ÜÁö°í ÀÖÀ¸¸ç, 1930³â´ë¿¡ óÀ½ µµÀÔµÈ ÀÌ·¡·Î ±â¼úÀûÀ¸·Î³ª ¾ÈÀü Ãø¸é¿¡¼­ ¸¹Àº °³¼±ÀÌ ÀÌ·ç¾îÁ³½À´Ï´Ù. Çö´ë Áø·á¿¡¼­ ȯÀÚ´Â ½Ã¼ú Àü¿¡ ±ÙÀ° ÀÌ¿ÏÁ¦¸¦ Åõ¿©Çϰí Àü½Å ¸¶Ã븦 ÇÕ´Ï´Ù. µÎÇÇÀÇ Æ¯Á¤ ºÎÀ§¿¡ Àü±ØÀ» ºÎÂøÇϰí Á¦¾îµÈ Àü·ù¸¦ ³ú¿¡ È帣°Ô ÇÏ¿© ªÀº ½Ã°£ µ¿¾È ¹ßÀÛÀ» ÀÏÀ¸Åµ´Ï´Ù. ECTÀÇ ÀÛ¿ë ±âÀüÀº ¾ÆÁ÷ ¿ÏÀüÈ÷ ¹àÇôÁöÁö ¾Ê¾ÒÁö¸¸, ƯÁ¤ Á¤½Å ÁúȯÀÇ Áõ»óÀ» ºü¸£°Ô ȸº¹½ÃŰ´Â ³ú È­ÇÐÀû º¯È­¸¦ ÀÏÀ¸Å°´Â °ÍÀ¸·Î »ý°¢µË´Ï´Ù. Ä¡·á¸¦ ÇÕ´Ï´Ù. ´Ü±âÀûÀÎ ºÎÀÛ¿ëÀ¸·Î´Â ´Ü±â ±â¾ï»ó½Ç, ¹æÇâ°¨°¢ »ó½Ç, Âø¶õ µîÀÌ ÀÖÀ» ¼ö ÀÖÁö¸¸, ´ë°³ ÀϽÃÀûÀÏ »ÓÀ̸ç, ECT´Â ƯÈ÷ ÀÚ»ì À§ÇèÀÌ ³ôÀº ÁßÁõ ¿ì¿ïÁõ ȯÀÚ³ª ¾à¹° Ä¡·á¸¦ °ßµðÁö ¸øÇϰųª ¹ÝÀÀÇÏÁö ¾Ê´Â ȯÀÚ¿¡°Ô´Â »ý¸íÀ» ±¸ÇÒ ¼ö ÀÖ´Â Ä¡·á¹ýÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Ä¡·á ¿É¼ÇÀ¸·Î¼­ ECT´Â ½ÅÁßÇÏ°Ô °í·ÁµÇ¾î¾ß Çϸç, ȯÀÚ¿Í °¡Á·, Ä¡·áÆÀ °£¿¡ À§Çè°ú ÀÌÀÍ¿¡ ´ëÇÑ ÃæºÐÇÑ ³íÀǰ¡ ÇÊ¿äÇϸç, ECT´Â ȯÀÚÀÇ ¾ÈÀü°ú µ¿ÀǸ¦ º¸ÀåÇϱâ À§ÇØ ¾ö°ÝÇÑ ÀÇ·á Áöħ¿¡ µû¶ó ½ÃÇàµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

Ä¡·á ÀúÇ×¼º ¿ì¿ïÁõ°ú °°Àº Á¤½Å ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¼¼°è Àü±â°æ·Ã¿ä¹ý ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2020³â Àü ¼¼°èÀûÀ¸·Î 2¾ï 6,400¸¸ ¸í ÀÌ»óÀÌ ¿ì¿ïÁõÀ» ¾Î°í ÀÖÀ¸¸ç, ¸Å³â ¾à 85¸¸ ¸íÀÌ ¿ì¿ïÁõÀ¸·Î »ç¸ÁÇϰí ÀÖ½À´Ï´Ù. ¾çÃø ´Ü½Ã°£ ÆÞ½º ÀÚ±ØÀ» ÅëÇÑ ±â¼úÀûÀ¸·Î Áøº¸ÇÑ ECT ÀåºñÀÇ µµÀÔÀÌ º¸±ÞÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

±×·¯³ª ECT¿¡ µû¸¥ µÎÅë, ¸Þ½º²¨¿ò, Âø¶õ, ±â¾ï»ó½Ç µîÀÇ ºÎÀÛ¿ëÀÌ Å« °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. Ç¥ÀûÈ­ °æµÎ°³ ÀÚ±âÀÚ±ØÀÇ °³¹ßÀº »õ·Î¿î ±âȸÀÔ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ Àü±â°æ·Ã¿ä¹ý ½ÃÀå - COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ Àü±â°æ·Ã¿ä¹ý ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â

Á¦6Àå ¼¼°èÀÇ Àü±â°æ·Ã¿ä¹ý ½ÃÀå, ¿ëµµº°, 2020-2032³â

Á¦7Àå ¼¼°èÀÇ Àü±â°æ·Ã¿ä¹ý ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

Á¦8Àå ¼¼°èÀÇ Àü±â°æ·Ã¿ä¹ý ½ÃÀå, Áö¿ªº°, 2020-2032³â

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ¼½¼Ç

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Electroconvulsive Therapy Market is estimated to be valued at USD 17.9 Mn in 2025 and is expected to reach USD 21.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 2.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 17.9 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 2.90% 2032 Value Projection: USD 21.8 Mn
Figure. Global Electroconvulsive Therapy Market Share (%), By Region 2025
Global Electroconvulsive Therapy Market - IMG1

Electroconvulsive Therapy (ECT) is a medical treatment most commonly used for patients with severe major depression or bipolar disorder that has not responded to other treatments. It involves a brief electrical stimulation of the brain while the patient is under anesthesia. Despite the stigma associated with its early use, ECT has significantly evolved and is considered a safe and effective intervention for certain psychiatric disorders. It was first introduced in 1930s, and has undergone numerous modifications in terms of both technique and safety. In modern practice, patients are given a muscle relaxant and put under general anesthesia before the procedure. Electrodes are placed at specific sites on the scalp, and a controlled electric current is passed through the brain, which causes a brief seizure. The mechanisms by which ECT works are still not fully understood, but it is believed to cause changes in brain chemistry that can quickly reverse symptoms of certain mental health conditions. ECT is typically administered two to three times a week, for a total of six to twelve treatments. The immediate side effects may include short-term memory loss, disorientation, and confusion, but these are usually transient. ECT can be life-saving, particularly for individuals with severe depression who are at high risk of suicide, or for those who cannot tolerate or do not respond to medication. As a treatment option, ECT must be considered with caution, and thorough discussions between the patient, their family, and the treatment team are necessary to address the risks and benefits. ECT is practiced under stringent medical guidelines to ensure patient safety and consent.

Market Dynamics:

Rising prevalence of mental health disorders such as treatment-resistant depression is a key driver augmenting the growth of global electroconvulsive therapy market. For instance, according to the World Health Organization (WHO), in 2020, more than 264 Mn people worldwide suffered from depression, and approximately 850,000 deaths are depression-related each year. Introduction of technologically advanced ECT devices with bilateral brief-pulse stimulus is further fueling the adoption.

However, side effects that are associated with ECT includes headache, nausea, confusion, and memory loss act as a major restraint. Development of targeted transcranial magnetic stimulation is an emerging opportunity.

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Electroconvulsive Therapy Market- Impact of Coronavirus (COVID-19) Pandemic

5. Global Electroconvulsive Therapy Market, By Product Type, 2020-2032, (US$ Mn)

6. Global Electroconvulsive Therapy Market, By Application, 2020-2032, (US$ Mn)

7. Global Electroconvulsive Therapy Market, By End User, 2020-2032, (US$ Mn)

8. Global Electroconvulsive Therapy Market, By Region, 2020-2032, (US$ Mn)

9. Competitive Landscape

10. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â